Financial Year |
March 31 2023 |
Monetary Funds |
4,821,037,370.90 |
Held-for-trading Financial Assets |
69,687,116.79 |
Notes Receivable |
-- |
Accounts Receivable |
58,827,684.03 |
Advances to Suppliers |
30,402,545.33 |
Other Receivables |
6,314,204.29 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
58,264,378.12 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
7,982,344.94 |
Total Current Assets |
5,052,515,644.40 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
81,013,083.47 |
Long-term Equity Investment |
695,530,859.00 |
Investment Properties |
35,960,029.37 |
Fixed Assetes |
639,396,929.17 |
Under-construction Projects |
7,643,389.07 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
15,266,582.82 |
R&D expenses |
-- |
Goodwill |
469,236.49 |
Long-Term Deferred and Prepaid Expenses |
96,157,206.72 |
Deferred Income Tax Assets |
43,960,547.68 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
3,704,582,029.35 |
Total Assets |
8,757,097,673.75 |
Short-Term Loans |
-- |
Trading Financial liabilities |
-- |
Notes Payable |
-- |
Accounts Payable |
852,593,503.18 |
Accounts Received In Advance |
14,290,707.11 |
Employee Compensation Payable |
18,678,550.78 |
Taxes Payable |
105,950,278.32 |
Interest Payable |
-- |
Dividend Payable |
549,127.74 |
Other payables |
1,272,989,912.02 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
-- |
Other Current Liabilities |
6,952,821.18 |
Sub-Total of Current Liabilities |
2,327,177,771.38 |
Long-term Loans |
-- |
Bonds Payable |
-- |
Long-Term Accounts Payable |
4,161,372.73 |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
51,425,188.01 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,893,577,927.34 |
Total Liabilities |
4,220,755,698.72 |
Paid-In Capital(Or Share Stock) |
735,933,058.00 |
Capital Surplus |
77,072,443.08 |
Surplus Reserve |
230,485,383.02 |
LESS:Treasury Stock |
35,279,504.85 |
Undistributed Profits |
2,285,373,132.60 |
Minority Stockholder's Interest |
1,141,132,463.18 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,395,209,511.85 |
Owner's Equity(Stockholder's Equity) |
4,536,341,975.03 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
8,757,097,673.75 |